Episodic memory-associated weighted atrophy network mapping in mild cognitive impairment and subjective cognitive decline: a multi-center study
This study localizes episodic memory-associated impaired networks in mild cognitive impairment (MCI) and subjective cognitive decline (SCD) using a weighted key atrophy network mapping method, and investigates whether repetitive transcranial magnetic stimulation (rTMS) can modulate them. Replicability was assessed across three independent cohorts involving 1312 subjects. First, single-subject key atrophy maps were constructed by comparing cortical thickness with cognitively normal groups and retaining regions showing significant thickness-memory correlations. Second, these maps served as seeds for functional connectivity analysis in a large normative connectome, generating atrophy networks weighted by atrophy extent. Third, group-level comparisons identified impaired networks in MCI and SCD, and methodological reliability was further validated against a memory network derived from patients with focal brain lesions. Finally, the impaired networks were experimentally modulated via a 4-week rTMS intervention (25 MCI, 13 SCD). Despite substantial individual-level heterogeneity, atrophied regions in most MCI patients were functionally connected to a common episodic memory-associated impaired network. This phenomenon was not significant in SCD patients. Both lesion-memory network mapping and cross-dataset validation confirmed consistency across cohorts. Critically, rTMS can modulate the impaired network in MCI patients, primarily reflected by enhanced functional connectivity within this network. In conclusion, this study developed a robust weighted key atrophy network mapping method, localizing common episodic memory-associated impaired networks in MCI/SCD. Modulation of this impaired network may serve as a potential therapeutic strategy to delay MCI progression.
Authors
- Jiu Chen (ORCID: https://orcid.org/0000-0001-8185-8575)
- Jia Fan (ORCID: https://orcid.org/0000-0002-0443-5904)
- Xingjian Lin (ORCID: https://orcid.org/0000-0003-3264-6773)
- Meizhao Qiao (ORCID: https://orcid.org/0009-0003-5176-7543)
- Lei Chi (ORCID: https://orcid.org/0009-0001-3173-0730)
- Haocheng Wang
- Shanshan Chen
- Zhichao Tong
- Yingxin Chen
- Anxing Huang
- Xinyi Yang
- Keke Jiang
- Huimin Wu
Institutions
- Nanjing University of Chinese Medicine (CN)
- University of Cape Town (ZA)
- Nanjing Brain Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
- Nanjing Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Translational Psychiatry
- Published
- 2026-10-30
- DOI
- https://doi.org/10.1038/s41398-026-04539-9
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Foundation for the National Institutes of Health
- Alzheimer's Association
- Eli Lilly and Company
- Biogen
- F. Hoffmann-La Roche
- Alzheimer's Disease Neuroimaging Initiative
- BioClinica
- Northern California Institute for Research and Education
- Ministry of Science and Technology of the People's Republic of China
- Government of Jiangsu Province
- Eisai
- Nanjing University
- Jiangsu Provincial Commission of Health and Family Planning
- IXICO
- Nanjing Drum Tower Hospital
- National Institutes of Health
- Genentech
- Canadian Institutes of Health Research
- Basic Research Program of Jiangsu Province